This initiative provides an opportunity to exchange information on best practices in the area of ethical business practices and global trends among participants in the defence and aerospace industry.
This initiative provides principles and guidelines to its members to help in the prevention of corruption in day-to-day business. The goal of this initiative is to develop common industry standards to be applied across Europe in the aerospace and defence industry. These Common Industry Standards are a set of business ethics requirements that assist European companies in implementing integrity programs. Highlights:
This initiative aims to increase access to essential medicines for people in developing countries, by increasing transparency and accountability in medicines procurement and supply chains to tackle inefficiency, corruption and fraud.
The Korean Pact for Anti-Corruption and Transparency (K-PACT) is a social pledge undertaken by actors at national level in the public and private sectors to establish corruption monitoring systems and to strengthen corporate ethics and social responsibility.
K-PACT is a national alliance made up of representatives from civil society, the public, private, and political sectors, committed to promoting and improving transparency in Korean society. Among the commitments made, this alliance has agreed to:
The Business Ethics Initiative seeks to promote anti-corruption and ethical business principles in Indonesia. Between 1999 and 2012, the Initiative:
This initiative, launched by the Russian business community, seeks to prevent and combat corruption by stating the corporate consensus against it, and setting forth measures to address corruption within and between companies, as well as between companies and government. The provisions of the charter apply to both the relations inside the business community and those between the business community and public authorities.
This initiative was created by the International Business Leaders Forum (IBLF) and brings together business, government and not-for-profit organizations to improve public procurement processes. The goals of this initiative are:
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code of Practice was first created in 1981 and is part of a decades-long commitment to promoting ethical practices in the pharmaceutical industry. The goal is to ensure that practices in the pharmaceutical industry are governed by ethical standards in line with societal expectations.
The Code has been revised six times since its inception. The current IFPMA Code of Practice came into effect on 1st January 2019, with the following changes compared to previous versions:
This initiative seeks to engage companies to make a clear stand on behalf of integrity and against corruption in Brazil, and to take measures to strengthen controls and transparency in public-private collaboration. The goals of the initiative are as follows:
The initiative arose in order to address the implementation gap in taxation, administrative barriers, and corruption at the regional level. It stems from a nine-year project of the Center for International Private Enterprise, seeking to improve the business environment for small and medium-sized enterprises in Russia.
Publications capturing the project’s best practices have been published by CIPE in Arabic and French. Anti-corruption and coalition-building techniques developed under the project have also been applied by CIPE in Ukraine, Thailand and Lebanon.